Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma

Nephron

Volumn 90, Issue 4, 2002, Pages 498-500

  Nakao, Kazushi ^a   Sugiyama, Hitoshi ^a   Makino, Eiichi ^a   Matsuura, Hironori ^a   Ohmoto, Akiko ^a   Sugimoto, Taro ^a   Ichikawa, Haruo ^a   Wada, Jun ^a   Yamasaki, Yasushi ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Interferon beta; Malignant melanoma; Minimal change nephrotic syndrome; Proteinuria

Indexed keywords

BETA INTERFERON; DACARBAZINE; NIMUSTINE; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MELANOMA; NEPHROTIC SYNDROME; PODOCYTE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; DIABETES MELLITUS; HUMANS; INTERFERON-BETA; KIDNEY GLOMERULUS; MALE; MELANOMA; MIDDLE AGED; NEPHROSIS, LIPOID; PROTEINURIA;

EID: 18344394555     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054740     Document Type: Article

References (4)

1. Hepatitis C virus-associated glomerulonephritis: Effect of alpha-interferon therapy
2. Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma
3. Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy
4. Minimal-change glomerulopathy and carcinoma: Report of two cases and review of the literature